Literature DB >> 22772799

Bacterial TIR-containing proteins and host innate immune system evasion.

Rohini R Rana1, Minghao Zhang, Abigail M Spear, Helen S Atkins, Bernadette Byrne.   

Abstract

The innate immune system provides the first line of host defence against invading pathogens. Key to upregulation of the innate immune response are Toll-like receptors (TLRs), which recognize pathogen-associated molecular patterns (PAMPs) and trigger a signaling pathway culminating in the production of inflammatory mediators. Central to this TLR signaling pathway are heterotypic protein-protein interactions mediated through Toll/interleukin-1 receptor (TIR) domains found in both the cytoplasmic regions of TLRs and adaptor proteins. Pathogenic bacteria have developed a range of ingenuous strategies to evade the host immune mechanisms. Recent work has identified a potentially novel evasion mechanism involving bacterial TIR domain proteins. Such domains have been identified in a wide range of pathogenic bacteria, and there is evidence to suggest that they interfere directly with the TLR signaling pathway and thus inhibit the activation of NF-κB. The individual TIR domains from the pathogenic bacteria Salmonella enterica serovar Enteritidis, Brucella sp, uropathogenic E. coli and Yersinia pestis have been analyzed in detail. The individual bacterial TIR domains from these pathogenic bacteria seem to differ in their modes of action and their roles in virulence. Here, we review the current state of knowledge on the possible roles and mechanisms of action of the bacterial TIR domains.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22772799     DOI: 10.1007/s00430-012-0253-2

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   4.148


  53 in total

1.  Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL.

Authors:  Javed A Khan; Elizabeth K Brint; Luke A J O'Neill; Liang Tong
Journal:  J Biol Chem       Date:  2004-04-30       Impact factor: 5.157

2.  TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog.

Authors:  Qing Zhang; Christian M Zmasek; Xiaohui Cai; Adam Godzik
Journal:  Dev Comp Immunol       Date:  2010-11-24       Impact factor: 3.636

3.  Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting.

Authors:  Martha Triantafilou; Frederick G J Gamper; Rowenna M Haston; Marios Angelos Mouratis; Siegfried Morath; Thomas Hartung; Kathy Triantafilou
Journal:  J Biol Chem       Date:  2006-07-31       Impact factor: 5.157

4.  Drosophila Toll and IL-1 receptor.

Authors:  N J Gay; F J Keith
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

5.  Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor.

Authors:  J Nigou; C Zelle-Rieser; M Gilleron; M Thurnher; G Puzo
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).

Authors:  Humera Ahmad; Rachel Gubbels; Erica Ehlers; Florencia Meyer; Thomas Waterbury; Rongtuan Lin; Luwen Zhang
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

7.  The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction.

Authors:  Daniel C Rowe; Anne F McGettrick; Eicke Latz; Brian G Monks; Nicholas J Gay; Masahiro Yamamoto; Shizuo Akira; Luke A O'Neill; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-07       Impact factor: 11.205

8.  The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.

Authors:  Tali Lang; Camden Lo; Narelle Skinner; Stephen Locarnini; Kumar Visvanathan; Ashley Mansell
Journal:  J Hepatol       Date:  2011-02-18       Impact factor: 25.083

9.  Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.

Authors:  Manisha Yadav; Jingyao Zhang; Hans Fischer; Wen Huang; Nataliya Lutay; Christine Cirl; Josephine Lum; Thomas Miethke; Catharina Svanborg
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

10.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

View more
  22 in total

1.  Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of the TIR domain from the Brucella melitensis TIR-domain-containing protein TcpB.

Authors:  Mohammed Alaidarous; Thomas Ve; M Obayed Ullah; Eugene Valkov; Ashley Mansell; Mark A Schembri; Matthew J Sweet; Bostjan Kobe
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-09-28

Review 2.  Elemental and chemically specific X-ray fluorescence imaging of biological systems.

Authors:  M Jake Pushie; Ingrid J Pickering; Malgorzata Korbas; Mark J Hackett; Graham N George
Journal:  Chem Rev       Date:  2014-08-07       Impact factor: 60.622

3.  A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.

Authors:  Fatemeh Askarian; Nina M van Sorge; Maria Sangvik; Federico C Beasley; Jørn R Henriksen; Johanna U E Sollid; Jos A G van Strijp; Victor Nizet; Mona Johannessen
Journal:  J Innate Immun       Date:  2014-01-25       Impact factor: 7.349

4.  Mechanism of bacterial interference with TLR4 signaling by Brucella Toll/interleukin-1 receptor domain-containing protein TcpB.

Authors:  Mohammed Alaidarous; Thomas Ve; Lachlan W Casey; Eugene Valkov; Daniel J Ericsson; M Obayed Ullah; Mark A Schembri; Ashley Mansell; Matthew J Sweet; Bostjan Kobe
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

Review 5.  The evolutionary journey of Argonaute proteins.

Authors:  Daan C Swarts; Kira Makarova; Yanli Wang; Kotaro Nakanishi; René F Ketting; Eugene V Koonin; Dinshaw J Patel; John van der Oost
Journal:  Nat Struct Mol Biol       Date:  2014-09       Impact factor: 15.369

6.  Staphylococcus aureus modulation of innate immune responses through Toll-like (TLR), (NOD)-like (NLR) and C-type lectin (CLR) receptors.

Authors:  Fatemeh Askarian; Theresa Wagner; Mona Johannessen; Victor Nizet
Journal:  FEMS Microbiol Rev       Date:  2018-09-01       Impact factor: 16.408

7.  Inhibitory Role of an Aeromonas hydrophila TIR Domain Effector in Antibacterial Immunity by Targeting TLR Signaling Complexes in Zebrafish.

Authors:  Huai-Ping Tang; Chen Huang; Chong-Bin Hu; Hao Li; Tong Shao; Jian-Fei Ji; Jun Bai; Dong-Dong Fan; Ai-Fu Lin; Li-Xin Xiang; Jian-Zhong Shao
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

Review 8.  Type IV secretion system of Brucella spp. and its effectors.

Authors:  Yuehua Ke; Yufei Wang; Wengfeng Li; Zeliang Chen
Journal:  Front Cell Infect Microbiol       Date:  2015-10-13       Impact factor: 5.293

9.  BtpB, a novel Brucella TIR-containing effector protein with immune modulatory functions.

Authors:  Suzana P Salcedo; María I Marchesini; Clara Degos; Matthieu Terwagne; Kristine Von Bargen; Hubert Lepidi; Claudia K Herrmann; Thais L Santos Lacerda; Paul R C Imbert; Philippe Pierre; Lena Alexopoulou; Jean-Jacques Letesson; Diego J Comerci; Jean-Pierre Gorvel
Journal:  Front Cell Infect Microbiol       Date:  2013-07-08       Impact factor: 5.293

10.  The Brucella TIR domain containing proteins BtpA and BtpB have a structural WxxxE motif important for protection against microtubule depolymerisation.

Authors:  Christine Felix; Burcu Kaplan Türköz; Sebastien Ranaldi; Thomas Koelblen; Laurent Terradot; David O'Callaghan; Annette Caroline Vergunst
Journal:  Cell Commun Signal       Date:  2014-10-12       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.